The effects of overexpression of human APP on cholinergic and dopaminergic neurons of brain of Drosophila melanogaster
- Authors: Bolshakova O.I.1, Zhuk A.A.2, Rodin D.I.2, Sarantseva S.V.2, Kislik G.A.2
-
Affiliations:
- B. P. Konstantinov Petersburg Nuclear Physics Institute
- B.P. Konstantinov Petersburg Nuclear Physics Institute
- Issue: Vol 11, No 1 (2013)
- Pages: 23-31
- Section: Articles
- URL: https://journals.rcsi.science/ecolgenet/article/view/2391
- DOI: https://doi.org/10.17816/ecogen11123-31
- ID: 2391
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Olga Igorevna Bolshakova
B. P. Konstantinov Petersburg Nuclear Physics Institute
Email: olya99991@yandex.ru
research associate
Anna Aleksandrovna Zhuk
B.P. Konstantinov Petersburg Nuclear Physics Institute
Email: azhukomi@mail.ru
senior technician
Dmitriy Igorevich Rodin
B.P. Konstantinov Petersburg Nuclear Physics Institute
Email: nomadkml@me.com
Junior Researcher
Svetlana Vladimirovna Sarantseva
B.P. Konstantinov Petersburg Nuclear Physics Institute
Email: svesar1@yandex.ru
Head of Laboratory, Ph.D
Galina Alekseevna Kislik
B.P. Konstantinov Petersburg Nuclear Physics Institute
Email: kislikgalina@hotmail.com
Junior Researcher
References
- Bonda J. D., Wang X., Gustaw-Rothenberg K. et al., 2009. Mitochondrial Drugs for Alzheimer Disease //Pharmaceuticals. Vol. 2. P. 287–298.
- Botella J., Bayersdorfer F., Schneuwly S., 2008. Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease // Neurobiology of Desease. Vol. 30. P. 75–73.
- Brand A. H., Perrimon N., 1993. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes // Development. Vol. 118. P. 401–415.
- Burns J. M., Galvin J. E., Roe C. M. et al., 2005. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs // Neurology. Vol. 64. P. 1397–1403.
- Cao X., Südhof T. C., 2001. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60 //Science. Vol. 293. P. 115–120.
- Cao X., Südhof T. C., 2004. Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation // J. Biol. Chem. Vol. 279. P. 24601–24611.
- Chen K. H., Reese E. A., Kim H-W. et al., 2011. Disturbed Neurotransmitter Transporter Expression in Alzheimer Disease Brain // J. Alzheimers Dis. Vol. 26. P. 755–766.
- Claasen A. M., Guévremont D., Mason-Parker S. E. et al., 2009. Secreted amyloid precursor protein-alpha upregulates synaptic protein synthesis by a protein kinase G-dependent mechanism. // Neur. Lett. Vol. 460. P. 92–96.
- Davies P., 1979. Neurotransmitter-related enzymes in senile dementia of Alzheimer type // Brain Res. Vol. 171. P. 319–327.
- Exley R., McIntosh J. M., Marks M. J. et al., 2012. Striatal α5 nicotinic receptor subunit regulates dopamine transmission in dorsal striatum // J. Neurosci. Vol. 32. P. 2352–2356.
- Francis P. T., Palmer A. M., Snape M., Wilcock G. K., 1999. The cholinergic hypothesis of Alzheimer’s disease: a review of progress // J. Neurol. Neurosurg. Psychiatry. Vol. 66. P. 137–147.
- Ghosal K., Vogt D. L., Liang M. et al., 2009. Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain // Proc. Natl. Acad. Sci. USA. Vol. 106. P. 18367–18372.
- Guan Z. Z., Zhang X., Ravid R., Nordberg A., 2000. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease // J. Neurochem. Vol. 74. P. 237–243.
- Hardy J., Selkoe D. J., 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. An updated summary of the amyloid hypothesis // Science. Vol. 297. P. 353–356.
- Iijima-Ando K., Iijima K., 2010. Transgenic Drosophila models of Alzheimer's disease and tauopathies //Brain Struct. Funct. Vol. 214. P. 245–262.
- Kar S., Slowikowski S.P, Westaway D, Mount H. T., 2004. Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer’s disease // J. Psychiatry Neurosci. Vol. 29. P. 427–468.
- Kazee A. M., Cox C., Richfield E. K., 1995. Substantia nigra lesions in Alzheimer disease and normal aging //Alzheimer Dis. Assoc. Disord. Vol. 9. P. 61–67.
- Kim H., Kim E., Lee J. et.al., 2003. C-terminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3β expression. // The FASEB Journal. Vol. 17. P. 1951–1953.
- Li Y., Liu T., Peng Y. et al., 2004. Specific functions of Drosophila amyloid precursor-like protein in the development of nervous system and nonneural tissues //J. Neurobiol. Vol. 61. P. 343–58.
- Luo L., Tully T., White K., 1992. Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for Appl gene // Neuron. Vol. 9. P. 595–605.
- Mesulam M. M., Mufson E. J., Wainer B. H., Levey A. I., 1983. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6) // Neuroscience. Vol. 10. P. 1185–1201.
- Mohandas E., Rajmohan V., Raghunath B., 2009. Neurobiology of Alzheimer's disease // Indian J. Psychiatry. Vol. 51. P. 55–61.
- Müller T., Concannon C. G., Ward M. W. et al. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD) // Biol. Cell. 2007. V. 18. P. 201–210.
- Müller U. C., Zheng H., 2012. Physiological Functions of APP Family Proteins // Cold Spring Harb Perspect Med. Vol. 2: a006288.
- Perez S. E., Lazarov O., Koprich J. B. et al., 2005. Nigrostriatal Dysfunction in Familial Alzheimer’s Disease-Linked APPswe/PS1-E9 Transgenic Mice // The Journal of Neuroscience Vol. 25. P. 10220 –10229.
- Perry E. K., Morris C. M., Court J. A. et al., 1995. Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology // Neurosci. Vol. 64. P. 385–395.
- Pimplikar S. W., Nixon R. A., Robakis N. K. et al., 2010. Amyloid-independent mechanisms in Alzheimer's disease pathogenesis // J. Neurosci. Vol. 30. P. 14946–14954.
- Sarantseva S., Timoshenko S., Bolshakova O. et al., 2009. Apolipoprotein E-Mimetics Inhibit Neurodegeneration and Restore Cognitive Functions in a Transgenic Drosophila Model of Alzheimer's Disease // PloS One. Vol. 4. e8191.
- Saura C. A., Choi S.-U., Beglopoulos V. et al. 2004. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration // Neuron. Vol. 42. P. 23–36.
- Schaeffer E. L., Gattaz W. F., 2008 Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme // Psychopharmacology. Vol. 198. P. 1–27.
- Stokin G. B., Almenar-Queralt A., Gunawardena S. et al., 2008. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides // Hum. Mol. Genet. Vol. 17. P. 3474–3486.
- Słomnicki L. P., Leśniak W., 2008. A putative role of the Amyloid Precursor Protein Intracellular Domain (AICD) in transcription // Acta Neurobiol. Exp (Wars). Vol. 68. P. 219–228.
- Sun C., Ou X., Farley J. M., Stockmeier C. et al., 2012. Allopregnanolone Increases the Number of Dopaminergic Neurons in Substantia Nigra of a Triple Transgenic Mouse Model of Alzheimer’s Disease // Curr. Alzheimer Res. Vol. 9. P. 473–480.
- Thinakaran G., Koo H. E., 2008. Amyloid Precursor Protein: Trafficking, Processing and Function // J. Biol. Chem. Vol. 283. P. 296–304.
- Tiraboschi P., Hansen L. A., Alford M. et al., 2000. The decline in synapses and cholinergic activity is asynchronous in Alzheimer’s disease // Neurology. Vol. 55. P. 1278–1283.
- Torroja L., Packard M., Gorczyca M. et al., 1999. Drosophila b-Amyloid Precursor Protein homolog promotes synapse differentiation at the neuromuscular junction // J. Neurosci. Vol. 15. P. 7793–7803.
- Tully T., Quinn W., 1985. Classical conditioning and retention in normal and mutant Drosophila melanogaster // Journal of Comparative Physiology. Vol. P. 263–277.
- Walsh D. M., Selkoe D. J., 2004. Deciphering the molecular basis of memory failure in Alzheimer's disease // Neuron. Vol. 44. P. 181–193.
- Whitehouse R. J., Price D. L., Struble R. G. et al., 1982. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain // Science. Vol. 215. P. 1237–1239.
- Yagi Y., Tomita S., Nakamura M. et al., 2000. Overexpression of human amyloid precursor protein in Drosophila // Mol. Cell. Biol. Res. Comm. Vol. 157. P. 263–277.